A team of researchers at UNSW Sydney & the California Institute of Biomedical Research (CALIBR) has found out success with an all-new, revolutionary cell-based immunotherapy for the treatment of pancreatic cancer. A new scientific way of providing treatment for advanced pancreatic cancer by making use of “killer cells” has shown immense hope & promise in the field of medical science.
The treatment has been conducted on mice and has been found to be completely cancer-free by getting rid of the cancer cells that might have already spread to lungs & liver. In the given study, the team of researchers took pancreatic cancer cells from the patients who were in the later stages of the disease. Then, the researchers transplanted the cancer cells into mice. After this, the team went forward with taking the immune cells of the patient and modifying them for specifically identifying and eliminating the tumor cells. This is the reason such immune cells are referred to as CAR-T cells or “educative killer cells.”
Professor Chris Heeschen stated that after the injection of the educative killer or CAR-T cells into mice, the team was able to find the cancer cells in the body, stick to the same with the help of surface markers, and then, eventually destroy the tumor cells. The treatment has been found to be so effective that the mice went cancer-free completely.
In addition to finding great hop for the treatment of advanced pancreatic cancer in the coming times, the team of researchers was also successful in introducing a new, revolutionary technology allowing the researchers to control the activity of the killer or CAR-T cells completely.